Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. More Details
Overvalued with worrying balance sheet.
Share Price & News
How has Decibel Cannabis's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: DB has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how DB performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how DB performed against the Canadian Market.
Price Volatility Vs. Market
How volatile is Decibel Cannabis's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StIs Decibel Cannabis (CVE:DB) Using Too Much Debt?
4 months ago | Simply Wall StAuditors Have Doubts About Decibel Cannabis (CVE:DB)
4 months ago | Simply Wall StAnalysts Have Just Cut Their Decibel Cannabis Company Inc. (CVE:DB) Revenue Estimates By 23%
Is Decibel Cannabis undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate DB's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate DB's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: DB is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: DB is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DB's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DB is good value based on its PB Ratio (0.8x) compared to the CA Pharmaceuticals industry average (1.5x).
How is Decibel Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Decibel Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of DB’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Decibel Cannabis competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Decibel Cannabis performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: DB is currently unprofitable.
Growing Profit Margin: DB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if DB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare DB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DB is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (30.9%).
Return on Equity
High ROE: DB has a negative Return on Equity (-35.3%), as it is currently unprofitable.
How is Decibel Cannabis's financial position?
Financial Position Analysis
Short Term Liabilities: DB's short term assets (CA$15.4M) exceed its short term liabilities (CA$12.1M).
Long Term Liabilities: DB's short term assets (CA$15.4M) do not cover its long term liabilities (CA$37.9M).
Debt to Equity History and Analysis
Debt Level: DB's debt to equity ratio (104.4%) is considered high.
Reducing Debt: Insufficient data to determine if DB's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: DB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.1% each year
What is Decibel Cannabis's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DB's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DB's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Benjamin Sze (37 yo)
Mr. Benjamin Sze is the Chief Executive Officer and Director at Decibel Cannabis Company Inc. (formerly known as Westleaf Inc.). since December 18, 2019. He has acted as a Director of WGBC since November 2 ...
|Chief Development Officer of Westleaf International Inc.||no data||CA$165.00k||no data|
|Chief Operating Officer of Westleaf International Inc.||no data||CA$165.00k||no data|
|Chief Legal Officer & VP of Strategy of Westleaf International Inc.||no data||CA$165.00k||no data|
|President||0.83yr||no data||0.34% |
|Interim Chief Financial Officer||0.42yr||no data||0.12% |
|Chief Compliance Officer||0.83yr||no data||0.092% |
|Executive Vice President of Commercial||0.83yr||no data||0.050% |
Experienced Management: DB's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
|President||0.83yr||no data||0.34% |
|Chairman||no data||no data||0.66% |
|Director||0.83yr||no data||0.14% |
|Independent Director||2.17yrs||CA$17.50k||0.068% |
|Director||0.83yr||no data||0.34% |
Experienced Board: DB's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: DB insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: DB only recently listed within the past 12 months.
Decibel Cannabis Company Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Decibel Cannabis Company Inc.
- Ticker: DB
- Exchange: TSXV
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$27.879m
- Shares outstanding: 348.49m
- Website: https://www.decibelcc.com
Number of Employees
- Decibel Cannabis Company Inc.
- 530 - 8th Avenue SW
- Suite 710
- T2P 3S8
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|DB||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Dec 2019|
|DBCC.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Dec 2019|
Decibel Cannabis Company Inc. engages the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower under the Qwest and Qwest Reserve brands; and cannab ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/25 01:13|
|End of Day Share Price||2020/10/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.